4.7. Patients
malignancy, HBV-related HCC, HCC
ONCOLOGY, COMPENSATED LIVER DISEASE
Patients with HBV-related HCC who underwent surgical resection within eight weeks were enrolled. Other major inclusion criteria included positive results for HBsAg, undetectable HBV DNA, compensated liver disease, normal fundoscopic examination, and an Eastern Cooperative Oncology Group Performance Status score of 0 to 1. The major exclusion criteria included HCC that was not related to HBV; vascular invasion of HCC in imaging diagnosis; patients who had undergone transcatheter arterial embolization or chemoembolization, transcatheter arterial infusion, or chemolipiodolization in combination with surgery; and a concurrent active malignancy other than HCC.